TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$39.81
1.47 (3.82%)
▲
5d:
+15.04%
30d:
+34.52%
90d:
+87.5%
HOLD
MODERATE Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TXG is 12.3% above its trading range ($35.46). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TXG is 12.3% above its trading range ($35.46). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $39.81, which is considered extended relative to its 30-day fair value range of $28.20 to $35.46. From a valuation perspective, the stock is trading at a premium (Forward PE: 191.7) compared to its historical average (130.3). At these levels, the market is pricing in 13.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TXG is in a uptrend. The price is approaching resistance at $35.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: TXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a uptrend. The price is approaching resistance at $35.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: TXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.20 -
$35.46
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
All Signals
- BEARISH: Price significantly overextended (+12.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BEARISH: Trading 28.0% above Wall St target ($27.62)
- NEUTRAL: Trading at premium valuation - market expects 13.7% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$28.20 -
$35.46
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.72
Resistance Level
$35.65
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
191.70
Wall Street Target
$27.62
(-28.0%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-3.5%
Valuation Premium vs History
+13.7% premium
PE vs Historical
191.7 vs 130.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+13.7%
(market-implied from PE analysis)
1-Year Target
$43.59
(+14%)
2-Year Target
$49.56
(+29%)
3-Year Target
$56.36
(+47%)
3-Yr Target (if PE normalizes)
(PE: 192→130)
PE COMPRESSION
$38.31
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 01, 2026 12:05 PM ET
Data refreshes hourly during market hours. Next update: 1:05 PM
Data refreshes hourly during market hours. Next update: 1:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 60 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 61 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 60 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 67 BUY |
